hexenoyl cap comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | Matches human GHRH(1-44) length |
| N-terminal modification | trans-3-hexenoyl group | Confers resistance to dipeptidyl peptidase IV |
| Appearance | White to off-white powder | Typically supplied lyophilized in a sealed vial |
| Solubility class | Freely soluble in water | Hydrophilic peptide; polar solvent compatible |
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Emerging methods for single-cell mass-spectrometry analysis promise to enable studying signal transduction with single-cell resolution. In notch signaling, direct contact between cells allows for precise control of cell differentiation during embryonic development. In the worm Caenorhabditis elegans, two cells of the developing gonad each have an equal chance of terminally differentiating or becoming a uterine precursor cell that continues to divide. The choice of which cell continues to divide is controlled by competition of cell surface signals. One cell will happen to produce more of a cell surface protein that activates the Notch receptor on the adjacent cell. This activates a feedback loop or system that reduces Notch expression in the cell that will differentiate and that increases Notch on the surface of the cell that continues as a stem cell.
==== World War I ==== In World War I, both Allied and Central Powers soldiers had relatively sufficient food supplies due to the static nature of trench warfare. British, French, Canadian, and ANZAC soldiers were regularly issued "dull" foods such as bully beef, biscuits, pudding, and Maconochie (tinned meat, potato, and vegetable stew), the latter of which was vilified for its poor quality, especially if not sufficiently heated. British Indian Army soldiers reportedly ate very well compared to their European comrades, with regular access to fresh food such as goat meat and rotis; British logistics also accommodated for vegetarian Indians by providing them with dal, gur, and milk instead of meat. This treatment was supposedly to prevent a mutiny similar to the Indian Rebellion of 1857, which was partially caused by indifference to Indian religious needs. The American Expeditionary Forces had a variety of different rations issued to them, organized based on freshness and purpose, and were generally considered well-fed compared to their British and European contemporaries. Imperial German Army soldiers had mostly the same foodstuffs with more reliance on potatoes over grains, but as the war progressed and food supplies lowered due to restrictions, the German military was forced to gradually reduce their meat rations, instituting meat-free days once per week and making meat a rarity among German soldiers.
=== Refrigeration === Supercritical carbon dioxide is also emerging as a useful high-temperature refrigerant, being used in new, CFC/HFC-free domestic heat pumps making use of the transcritical cycle. These systems are undergoing continuous development with supercritical carbon dioxide heat pumps already being successfully marketed in Asia. The EcoCute systems from Japan are some of the first commercially successful high-temperature domestic water heat pumps.
Sources: en.wikipedia.org
Anaesthesia Dental Surgery Emergency Medicine Family Medicine Family Dentistry Internal Medicine Obstetrics and Gynaecology Ophthalmology Orthopaedics Otorhinolaryngology (ENT) Paediatrics Pathology Psychiatry Public Health and Community Medicine Radiology Surgery
== Early life and education == Phil S. Baran was born in Denville, New Jersey, on August 10, 1977, and grew up in Coral Springs, Florida. He was not a strong academic student in high school, but developed early interests in creative pursuits like role-playing games, computer programming, and Lego building. Encouraged by his chemistry teacher to experiment after school, Baran quickly channeled his creativity into crafting molecules. In 1995 he began a chemistry degree at New York University, and enthusiastically accepted David Schuster's offer to work in his lab, synthesizing compounds that linked C60 with porphyrins to make artificial photosynthetic systems. He received his BS in chemistry from New York University in 1997. He went on to earn his PhD from The Scripps Research Institute in 2001, under the supervision of K. C. Nicolaou, an experience he recalls was 'like hardcore Navy Seal training' and where he co-authored 30 papers in less than four years. He then pursued a postdoctoral fellowship in the laboratory of Nobel Laureate Elias James Corey at Harvard University who reflected on Baran's time in his lab, saying, "He had a phenomenal grasp of synthetic chemistry," and "felt that he could be a leader in his generation." Baran is married to Mariana Baran and has four children.
=== Cannabinoid hyperemesis syndrome === Aprepitant has been identified as having strong potential in treating protracted vomiting episodes in individuals with cannabinoid hyperemesis syndrome. This syndrome is characterized by nausea, cyclical vomiting, and cramping abdominal pain resulting from prolonged, frequent cannabis use. Standard first-line antiemetics such as ondansetron and prochlorperazine are often ineffective in treating cannabinoid hyperemesis syndrome.
Sources: en.wikipedia.org
== See also == Drug disposal – Safe disposal of unused drugs Electronic waste – Discarded electronic devices Human waste – Feces and urine List of waste management topics List of waste types Incineration – Waste treatment process Universal precautions – Medical standard for contact avoidance
=== Nuclear Magnetic Resonance Spectroscopy === NMR spectroscopy plays a crucial role in characterizing cage formation and dynamics in solution. Solution-state NMR allows researchers to monitor reaction progress and confirm structural features through chemical shift analysis and coupling patterns. Two-dimensional NMR techniques help establish connectivity patterns and verify the successful formation of key structural features. This solution-phase characterization complements solid-state analysis by providing insight into the cage's behavior under practical application conditions.
Armaan Kohli, Indian actor Bisham Kohli, Indian film personality, better known as Vishal Anand Girish Kohli (born 1983), Indian author and screenwriter Gurdeep Kohli (born 1980), Indian actor Hardeep Singh Kohli (born 1969), British presenter Himansh Kohli (born 1989), Indian actor Jas Kohli, Indian author Kuku Kohli (born 1949), Indian director, writer, editor and screenwriter Kunal Kohli (born 1969), Indian film director, producer and writer Narendra Kohli (1940–2021), Indian Hindi-language author Neelu Kohli, Indian television actress Nishi (actress) (born 1935), Indian actor Purab Kohli (born 1979), Indian actor, model and former video jockey Rahul Kohli, English actor Rajkumar Kohli (1930–2023), Indian film director Raul Kohli, English standup comedian Rochak Kohli (born 1983), Indian music director, composer, singer, instrumentalist and lyricist Sanjeev Kohli (born 1971), British Indian comedian, writer and actor Seema Kohli, Indian artist Sunita Kohli, Indian interior designer Vikas Kohli, Indian musician and music producer
They had planned to wed in summer 2020 but postponed the event twice due to the COVID-19 pandemic. At her wedding, Alizée wore the 1980s wedding dress belonging to Carole Middleton, her mother-in-law. The couple welcomed their first child, Inigo Gabriel, on 21 September 2023.
Sources: en.wikipedia.org
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.
No. It is a receptor agonist that stimulates the pituitary to release endogenous growth hormone. It does not contain or deliver growth hormone. Its downstream effects therefore depend on a functioning pituitary and an intact signaling pathway.
Pituitary responsiveness, receptor availability, and the natural pulsatility of the growth hormone axis all contribute. Because the compound amplifies an existing release pattern rather than overriding it, timing and physiological state matter. Individual variability in response is well documented but not fully explained.
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.